These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7040411)

  • 1. Antibodies specific for DNA components structurally modified by chemical carcinogens.
    Müller R; Rajewsky MF
    J Cancer Res Clin Oncol; 1981; 102(2):99-113. PubMed ID: 7040411
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunochemical approach for the characterization of DNA damages induced by chemical carcinogens.
    Tada M; Morita T
    Nucleic Acids Symp Ser; 1988; (19):73-6. PubMed ID: 3147452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of antibody affinity in the performance of immunoassays for antibody.
    Steward MW; Lew AM
    J Immunol Methods; 1985 Apr; 78(2):173-90. PubMed ID: 2580911
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved conditions for the production of monoclonal antibodies to carcinogen-modified DNA, for use in enzyme-linked immunosorbent assays (ELISA).
    Hertzog PJ; Shaw A; Lindsay Smith JR; Garner RC
    J Immunol Methods; 1983 Aug; 62(1):49-58. PubMed ID: 6409964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoaffinity chromatography of carcinogen DNA adducts with polyclonal antibodies directed against benzo[a]pyrene diol-epoxide-DNA.
    Tierney B; Benson A; Garner RC
    J Natl Cancer Inst; 1986 Jul; 77(1):261-7. PubMed ID: 3459918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological quantification by high-affinity antibodies of O6-ethyldeoxyguanosine in DNA exposed to N-ethyl-N-nitrosourea.
    Müller R; Rajewsky MF
    Cancer Res; 1980 Mar; 40(3):887-96. PubMed ID: 7471102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoassay of carcinogen-modified DNA.
    Strickland PT; Boyle JM
    Prog Nucleic Acid Res Mol Biol; 1984; 31():1-58. PubMed ID: 6085171
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monoclonal antibodies to DNA, modified with osmium tetraoxide in the presence of 2,2'-bipyridine].
    Kabakov AE; Brovkina LN; Podgordnichenko VK; Poverennyĭ AM
    Bioorg Khim; 1991 Oct; 17(10):1386-9. PubMed ID: 1804122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of enzyme-linked immunosorbent assay for specific antibodies with high sensitivity and studies on immunization processes in experimental animals].
    Tanimori H
    Tanpakushitsu Kakusan Koso; 1987 Sep; (31 Suppl):227-33. PubMed ID: 3423271
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-dextran antibodies of carp detected by the enzyme-linked immunosorbent assay (ELISA).
    Richter RF; Ambrosius H
    Allerg Immunol (Leipz); 1988; 34(4):269-73. PubMed ID: 2465680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of antibodies against 3,2'-dimethyl-4-aminobiphenyl-modified DNA.
    Tada M; Aoki H; Kojima M; Morita T; Shirai T; Yamada H; Ito N
    Carcinogenesis; 1989 Aug; 10(8):1397-402. PubMed ID: 2752513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to carcinogen-DNA adducts.
    Poirier MC
    J Natl Cancer Inst; 1981 Sep; 67(3):515-9. PubMed ID: 6944523
    [No Abstract]   [Full Text] [Related]  

  • 13. An ELISA for detection of DNA-bound carcinogen using a monoclonal antibody to N-acetoxy-2-acetylaminofluorene-modified DNA.
    Ball SS; Quaranta V; Shadravan F; Walford RL
    J Immunol Methods; 1987 Apr; 98(2):195-200. PubMed ID: 3571986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against human angiotensinogen, their characterization and use in an angiotensinogen enzyme linked immunosorbent assay.
    Rubin I; Lykkegaard S; Olsen AA; Selmer J; Ballegaard M
    J Immunoassay; 1988; 9(3-4):257-74. PubMed ID: 2466873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity monoclonal antibodies to PED/PEA-15 generated using 5 microg of DNA.
    Kilpatrick KE; Danger DP; Hull-Ryde EA; Dallas W
    Hybridoma; 2000 Aug; 19(4):297-302. PubMed ID: 11001402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological detection of lesions in DNA.
    Leng M
    Biochimie; 1985; 67(3-4):309-15. PubMed ID: 3899185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides.
    Terheggen PM; Floot BG; Lempers EL; van Tellingen O; Begg AC; den Engelse L
    Cancer Chemother Pharmacol; 1991; 28(3):185-91. PubMed ID: 1855275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an ELISA system for determination of class-specific antibodies to native and denatured DNA in man.
    Halliday GM; Salaman MR; Seifert MH; Johnson KJ; Malcolm AD
    Ann Rheum Dis; 1985 Aug; 44(8):507-13. PubMed ID: 3896167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to carcinogen-DNA adducts in mice chronically exposed to polycyclic aromatic hydrocarbons.
    Lee BM; Strickland PT
    Immunol Lett; 1993 May; 36(2):117-23. PubMed ID: 8349308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding efficiency of antibodies to DNA modified with aromatic amines and polycyclic aromatic hydrocarbons: implications for quantification of carcinogen-DNA adducts in vivo.
    Kriek E; Van Schooten FJ; Hillebrand MJ; Welling MC
    IARC Sci Publ; 1988; (89):201-7. PubMed ID: 3143670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.